CAMBRIDGE, Mass.--(BUSINESS WIRE)--Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company, announced today that it will report financial results for the second quarter on Thursday, August 4, 2016, after the U.S. financial markets close.
Management will provide an update on the company, discuss second quarter 2016 results, and discuss expectations for the future via conference call on Thursday, August 4, 2016 at 4:30 p.m. ET.
